Trials / Conditions / Basal Cell Nevus Syndrome

Basal Cell Nevus Syndrome

16 registered clinical trials studyying Basal Cell Nevus Syndrome — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Reproductive Options in Inherited Skin Diseases NCT06330324	Maastricht University Medical Center	—
Recruiting	Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350	Maastricht University Medical Center	—
Recruiting	Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registrati NCT05463757	Maastricht University Medical Center	—
Completed	Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor NCT04416516	Ascend Biopharmaceuticals Ltd	Phase 2
Terminated	Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) NCT04308395	Sol-Gel Technologies, Ltd.	Phase 3
Withdrawn	Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome NCT03767439	Columbia University	Phase 2
Completed	Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell NCT03703310	Sol-Gel Technologies, Ltd.	Phase 3
Completed	Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma NCT03467789	Case Comprehensive Cancer Center	Phase 1
Completed	Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas NCT02762084	PellePharm, Inc.	Phase 2
Completed	Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome NCT02157623	Edward Maytin, MD, PhD	N/A
Completed	A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma NCT02550678	Ascend Biopharmaceuticals Ltd	Phase 1 / Phase 2
Terminated	Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma NCT02303041	Anne Chang	Phase 2
Completed	Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome NCT02100371	University Health Network, Toronto	N/A
Completed	Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas NCT01556009	UCSF Benioff Children's Hospital Oakland	Phase 2
Completed	To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) NCT00957229	UCSF Benioff Children's Hospital Oakland	Phase 2
Completed	Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients NCT00555633	Medical University of Graz	—